In a genome‐wide CRISPR‐Cas9‐based genetic screening study carried out with the GeCKO library in two bladder cancer cell lines, MSH2, MLH1, FAM89B, XPC and PMS2 were identified as the top five candidate genes. This evidence concerns the gene PMS2 and urinary bladder carcinoma.